Exodus Point Capital Management, LP Cytokinetics Inc Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 117,984 shares of CYTK stock, worth $6.45 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

117,984

Previous 92,933 26.96%

Holding current value

$6.45 Million

Previous $5.04 Million 23.73%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$51.22 - $60.16 $1.28 Million - $1.51 Million	25,051 Added 26.96%	117,984 $6.23 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $2.28 Million - $3.58 Million	47,669 Added 105.31%	92,933 $5.04 Million
Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $10.2 Million - $17.2 Million	-159,469 Reduced 77.89%	45,264 $3.17 Million
Q3 2023 Nov 09, 2023	SELL	$29.46 - $36.61 $240,364 - $298,700	-8,159 Reduced 3.83%	204,733 $6.03 Million
Q2 2023 Aug 10, 2023	SELL	$32.62 - $40.75 $1.88 Million - $2.35 Million	-57,557 Reduced 21.28%	212,892 $6.95 Million
Q1 2023 May 11, 2023	BUY	$33.36 - $45.71 $3.64 Million - $4.99 Million	109,116 Added 67.63%	270,449 $9.52 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $5.77 Million - $8.25 Million	161,333 New	161,333 $7.39 Million
Q3 2022 Nov 10, 2022	SELL	$38.54 - $54.52 $3.81 Million - $5.38 Million	-98,740 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$33.93 - $48.92 $3.35 Million - $4.83 Million	98,740 New	98,740 $3.88 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $773,626 - $1.2 Million	-26,013 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $1.74 Million - $2.35 Million	-50,572 Reduced 66.03%	26,013 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $835,597 - $1.61 Million	45,070 Added 143.01%	76,585 $2.74 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $434,806 - $592,997	-21,971 Reduced 41.08%	31,515 $624,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $993,235 - $1.37 Million	53,486 New	53,486 $1.24 Million
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $169,610 - $315,959	-19,384 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $154,102 - $229,506	19,384 New	19,384 $206,000

Others Institutions Holding CYTK

# of Institutions

407

Shares Held

125M

Call Options Held

4.52M

Put Options Held

2.28M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.15B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Cytokinetics Inc Transaction History